CoChat

Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice

Miyakoshi, N. · 2001 · Endocrinology
Cited by 155

The DOI matches its Crossref record.

Abstract

Although it has been established that PTH exerts potent anabolic effects on bone in animals and humans, the mechanism of PTH action on bone remains controversial. Based on the previous findings that PTH treatment increased production of IGF-I in bone cells and that PTH effects on bone cells in vitro were blocked by IGF-I-blocking antibodies, we proposed that IGF-I action is required for the stimulatory effects of PTH on bone formation. To test this hypothesis, we evaluated the effects of PTH on bone formation parameters in growing mice lacking functional IGF-I genes. Five-week-old IGF-I(-/-) mice and wild-type littermates were given daily sc injections of 160 microg/kg body weight of PTH (1-34) or vehicle for 10 d. In wild-type animals, PTH caused a significant increase in serum osteocalcin levels (113%), serum alkaline phosphatase activity (48%), and alkaline phosphatase activity in femoral bone extracts (>80%), compared with the vehicle-treated control group. In contrast, in IGF-I(-/-) mice, there was no significant effect of PTH on any bone formation parameters. PTH treatment increased total bone mineral density, as evaluated by peripheral quantitative computer tomography, at the distal metaphysis of the femur by 40% in wild-type mice, but it had no effect on bone mineral density in mice lacking functional IGF-I genes. In vitro studies using osteoblasts derived from control and IGF-I(-/-) mice revealed that PTH treatment increased cell number in osteoblasts derived from IGF-I knockout mice in the presence of exogenously added IGF-I but not without IGF-I. These data to our knowledge provide the first direct evidence that the anabolic effects of PTH on bone formation in vivo require IGF-I action in growing mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.142.10.4349

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 48

  1. Reeve, 1980, Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial., BMJ, 280, 1340, 10.1136/bmj.280.6228.1340 · DOI · Paper page
  2. Slovik, 1986, Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D., J Bone Miner Res, 1, 377, 10.1002/jbmr.5650010411 · DOI · Paper page
  3. Gunness-Hey, 1984, Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone., Metab Bone Dis Relat Res, 5, 177, 10.1016/0221-8747(84)90026-2 · DOI · Paper page
  4. Gera, 1987, Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats., Calcif Tissue Int, 40, 206, 10.1007/BF02556623 · DOI
  5. Malluche, 1982, Effects of long-term infusion of physiologic doses of 1–34 PTH on bone, Am J Physiol, 242, F197
  6. Hock, 1988, Human parathyroid hormone-(1–34) increases bone mass in ovariectomized and orchidectomized rats., Endocrinology, 122, 2899, 10.1210/endo-122-6-2899 · DOI · Paper page
  7. Hori, 1988, Effect of human parathyroid hormone (PTH(1–34)) on experimental osteopenia of rats induced by ovariectomy., Bone Miner, 3, 193
  8. Tada, 1990, Restoration of axial and appendicular bone volumes by h-PTH(1–34) in parathyroidectomized and osteopenic rats., Bone, 11, 163, 10.1016/8756-3282(90)90210-P · doi:10.1016/8756-3282(90)90210-p
  9. Shen, 1992, Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1–34) and 17 β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia., Calcif Tissue Int, 50, 214, 10.1007/BF00296285 · DOI
  10. Liu, 1991, Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone., J Bone Miner Res, 6, 1071, 10.1002/jbmr.5650061008 · DOI
  11. Kimmel, 1993, The effect of recombinant human (1–84) or synthetic human (1–34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats., Endocrinology, 132, 1577, 10.1210/endo.132.4.8462456 · doi:10.1210/endo.132.4.8462456
  12. Ma, 1995, Human parathyroid hormone-(1–38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats., J Bone Miner Res, 10, 496, 10.1002/jbmr.5650100322 · DOI · Paper page
  13. Mohan, 2000, Comparison of bone formation responses to PTH (1–34), PTH (1–31) and PTH (2–34) in mice., Bone, 27, 471, 10.1016/S8756-3282(00)00355-0 · DOI
  14. Jilka, 1999, Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone., J Clin Invest, 104, 439, 10.1172/JCI6610 · DOI · Paper page
  15. Kronenberg, 1998, Functional analysis of the PTH/PTHrP network or ligands and receptors., Recent Prog Horm Res, 53, 283
  16. Lee, 1994, Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids., Endocrinology, 134, 441, 10.1210/endo.134.1.8275957 · DOI · Paper page
  17. Onishi, 1997, The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors., J Bone Miner Res, 12, 1596, 10.1359/jbmr.1997.12.10.1596 · DOI
  18. Cole, 1999, Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells., Endocrinology, 140, 5771, 10.1210/endo.140.12.7173 · DOI
  19. Verheijen, 1995, Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway., Endocrinology, 136, 3331, 10.1210/endo.136.8.7628368 · DOI
  20. McCarthy, 1989, Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone., Endocrinology, 124, 1247, 10.1210/endo-124-3-1247 · DOI · Paper page
  21. Linkhart, 1989, Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture., Endocrinology, 125, 1484, 10.1210/endo-125-3-1484 · DOI · Paper page
  22. Watson, 1995, Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats., Bone, 16, 357, 10.1016/8756-3282(94)00051-4 · DOI · Paper page
  23. Canalis, 1989, Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures., J Clin Invest, 83, 60, 10.1172/JCI113885 · DOI · Paper page
  24. Ishizuya, 1997, Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells., J Clin Invest, 99, 2961, 10.1172/JCI119491 · DOI · Paper page
  25. Harvey, 1999, Parathyroid hormone-(1–34) enhances aggrecan synthesis via an insulin-like growth factor-I pathway., J Biol Chem, 274, 23249, 10.1074/jbc.274.33.23249 · doi:10.1074/jbc.274.33.23249
  26. Hock, 1990, Anabolic effect of human synthetic parathyroid hormone-(1–34) depends on growth hormone., Endocrinology, 127, 1804, 10.1210/endo-127-4-1804 · DOI
  27. Schmidt, 1995, Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats., Endocrinology, 136, 5127, 10.1210/endo.136.11.7588250 · doi:10.1210/endo.136.11.7588250 · Paper page
  28. Gunness, 1995, Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor I (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet., Bone, 16, 199, 10.1016/8756-3282(94)00030-4 · DOI
  29. Hock, 1995, Growth hormone does not enhance the anabolic effect of human parathyroid hormone (1–34) on bone in aging multiparous and virgin rats., Mech Ageing Dev, 85, 183, 10.1016/0047-6374(95)01662-7 · DOI
  30. Liu, 1993, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)., Cell, 75, 59
  31. Lembo, 1996, Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency., J Clin Invest, 98, 2648, 10.1172/JCI119086 · DOI
  32. Beamer, 1996, Genetic variability in adult bone density among inbred strains of mice., Bone, 18, 397, 10.1016/8756-3282(96)00047-6 · DOI · Paper page
  33. Rosen, 1997, Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities., Bone, 21, 217, 10.1016/S8756-3282(97)00143-9 · DOI · Paper page
  34. Jamsa, 1998, Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia., Bone, 23, 155, 10.1016/S8756-3282(98)00076-3 · DOI · Paper page
  35. Mohan, 1995, Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation., J Clin Endocrinol Metab, 80, 637
  36. Srivastava, 2000, Development and application of a synthetic peptide-based osteocalcin assay for the measurement of bone formation in mouse serum., Calcif Tissue Int, 67, 255, 10.1007/s002230001109 · DOI
  37. Farley, 1994, Specific activity of skeletal alkaline phosphatase in human osteoblast-line cells regulated by phosphate, phosphate esters, and phosphate analogs and release of alkaline phosphatase activity inversely regulated by calcium., J Bone Miner Res, 9, 497, 10.1002/jbmr.5650090409 · DOI
  38. Ernst, 1988, Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I., Biochem Biophys Res Commun, 151, 142, 10.1016/0006-291X(88)90570-0 · DOI · Paper page
  39. Gray, 1989, Estradiol stimulates in vitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106., Biochem Biophys Res Commun, 158, 407, 10.1016/S0006-291X(89)80062-2 · DOI
  40. Cheng, 1999, Mechanical strain stimulates ROS cell proliferation through IGF-II and estrogen through IGF-I., J Bone Miner Res, 14, 1742, 10.1359/jbmr.1999.14.10.1742 · doi:10.1359/jbmr.1999.14.10.1742
  41. Gori, 1999, Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line., Endocrinology, 140, 5579, 10.1210/endo.140.12.7213 · doi:10.1210/endo.140.12.7213 · Paper page
  42. Huang, 2000, Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts., J Bone Miner Res, 15, 188, 10.1359/jbmr.2000.15.2.188 · DOI · Paper page
  43. Miyakoshi, 2001, Evidence that IGF-binding protein-5 functions as a growth factor., J Clin Invest, 107, 73, 10.1172/JCI10459 · DOI · Paper page
  44. Zhang, 1999, ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells., J Bone Miner Res, 14, 528, 10.1359/jbmr.1999.14.4.528 · DOI · Paper page
  45. Merriman, 1990, Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells., Calcif Tissue Int, 46, 258, 10.1007/BF02555005 · DOI
  46. Furlanetto, 1994, Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro., Mol Endocrinol, 8, 510
  47. Yakar, 1999, Normal growth and development in the absence of hepatic insulin-like growth factor I., Proc Natl Acad Sci USA, 96, 7324, 10.1073/pnas.96.13.7324 · DOI · Paper page
  48. Sjogren, 1999, Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice., Proc Natl Acad Sci USA, 96, 7088, 10.1073/pnas.96.12.7088 · DOI · Paper page

Cited by

See all 155

Metadata

Authors
Miyakoshi, N.
Venue
Endocrinology
Published
2001-10-01
Volume
142
Issue
10
Pages
4349-4356
ISSN
0013-7227 (ISSN-L)
OpenAlex
W2171087186
Cited by
155
References
0
FWCI
4.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice. https://app.cochat.ai/papers/10.1210/en.142.10.4349
The paper
Miyakoshi, N. (2001). Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice. Endocrinology. https://doi.org/10.1210/en.142.10.4349

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.